Mitsubishi Tanabe To Develop New Vaccines With Canadian Medicago
This article was originally published in PharmAsia News
Executive Summary
Mitsubishi Tanabe Pharma Corp and Canadian biotech Medicago Inc. March 7 signed a collaboration to develop and commercialize new vaccines using plant-based technology of virus-like particles developed by Medicago.